Lucintel Forecasts the Global Onychomycosis Treatment Market to Reach $4.3 billion by 2030
https://www.lucintel.com/onychomycosis-treatment-market.aspx
According to a market report by Lucintel, the future of the global onychomycosis treatment market looks promising with opportunities in the hospital and clinic, online store, and retail pharmacy markets. The global onychomycosis treatment market is expected to reach an estimated $4.3 billion by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are rising cases of onychomycosis among the general population and introduction of water-soluble antifungal treatment solutions.
A more than 150 — page report is developed to understand Trends, opportunity and forecast in onychomycosis treatment market to 2030 by disease type (distal subungual onychomycosis, proximal subungual onychomycosis, white superficial onychomycosis, candidal onychomycosis, and others), treatment type (laser therapy, photodynamic therapy, and drug treatment), drug class (allylamine, azole, griseofulvin, and others), distribution channel (hospitals and clinics, online stores, retail pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
In this market, distal subungual, proximal subungual, white superficial, and candidal are the major segments of onychomycosis treatment market by disease type. Lucintel forecasts that distal subungual will remain the largest segment over the forecast period.
Within this market, retail pharmacy is expected to witness the highest growth over the forecast period.
North America will remain the largest region over the forecast period.
Bausch Health, Cipla, Dr. Reddy’s Laboratories, Galderma, GlaxoSmithKline, Kaken Pharmaceutical, Lumenis, Moberg Pharma, Novartis, and Pfizer are the major suppliers in the onychomycosis treatment market.
Download sample by clicking on onychomycosis treatment market
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1–972–636–5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Neglected Tropical Disease Diagnosis Market in Canada
Orthopedic Biomaterial Market in Canada
Plastic Cable Puller Market in Canada
Polymer Separation Membrane Market in Canada